Accumulation of senescent cells in the tumour microenvironment can drive tumourigenesis in a paracrine manner through the senescence-associated secretory phenotype (SASP). Using a new p16-FDR mouse line, we show that macrophages and endothelial cells are the
predominant senescent cell types in murine KRAS-driven lung tumours. Through single cell transcriptomics, we identify a population of tumour-associated macrophages that express a unique array of pro-tumourigenic SASP factors and surface proteins and are also present in normal aged lungs. Genetic or senolytic ablation of senescent cells, or macrophage depletion, result in a significant reduction in tumour burden and increased survival in KRAS-driven lung
cancer models. Moreover, we reveal the presence of macrophages with senescent features in human lung premalignant lesions, but not in adenocarcinomas. Taken together, our results have uncovered the important role of senescent macrophages in the initiation and progression
of lung cancer, highlighting potential therapeutic avenues and cancer preventative strategies.